← Open Payments lookup

SAMYA ISMAIL: Open Payments

NPI 1801498084 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,264 in 53 payments from 13 companies in 2025. Trend: 2023 $1,173 · 2024 $765 · 2025 $1,264

Food & beverage: $1,264
CompanyPaymentsAmount
GENZYME CORPORATION11$363
ARS Pharmaceuticals Operations, Inc.14$232
BioCryst US Sales Co., LLC11$231
Novartis Pharmaceuticals Corporation5$132
GlaxoSmithKline, LLC.3$76
AstraZeneca Pharmaceuticals LP2$55
Takeda Pharmaceuticals U.S.A., Inc.1$34
CSL Behring1$29
Paratek Pharmaceuticals, Inc.1$26
ABBVIE INC.1$25

Products named: DUPIXENT, NEFFY, ORLADEYO, NUCALA, FASENRA, Xhance, TAKHZYRO, AYVAKIT.

Industry payments across NY — which companies pay providers there.